Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Immunomodulatory therapies delay disease progression in multiple sclerosis.
FTY720 (fingolimod) efficacy in an animal model of multiple sclerosis requires astrocyte sphingosine 1-phosphate receptor 1 (S1P1) modulation.
Fine Mapping and Functional Analysis of the Multiple Sclerosis Risk Gene CD6.
[New treatment options in multiple sclerosis and their complications].
Correlation between brain volume loss and clinical and MRI outcomes in multiple sclerosis.
RORγt, but not T-bet, overexpression exacerbates an autoimmune model for multiple sclerosis.
Immunological differences between classical phenothypes of multiple sclerosis.
FTY720 (fingolimod) treatment tips the balance towards less immunogenic antigen-presenting cells in patients with multiple sclerosis.
Effect of IL-17A blockade with secukinumab in autoimmune diseases.
Activation of CD4(+) Foxp3(+) regulatory T cells proceeds normally in the absence of B cells during EAE.
Flash Pulmonary Edema in Multiple Sclerosis.
Prognostic factors of acute partial transverse myelitis.
Bilateral idiopathic optic neuritis in pregnancy.
Quantitative determination of regional lesion volume and distribution in children and adults with relapsing-remitting multiple sclerosis.
Substance Name: ONO 4641
Multiple sclerosis and seizures: incidence and prevalence over 40 years.
Brain circuitry outside the synaptic cleft.
The myelin oligodendrocyte glycoprotein directly binds nerve growth factor to modulate central axon circuitry.
A Surprisingly Low Prevalence of Demonstrable Stress Urinary Incontinence and Pelvic Organ Prolapse in Women with Multiple Sclerosis Followed at a Tertiary Neurogenic Bladder Clinic.
Pulmonary Hypertension and Multiple Sclerosis - Coincidence or Association?
Validity and reliability of Persian version of Modified Fatigue Impact Scale (MFIS) questionnaire in Iranian patients with multiple sclerosis.
ENCOMS: Argentinian survey in cost of illness and unmet needs in multiple sclerosis.
Riluzole interacts with voltage-activated sodium and potassium currents in cultured rat cortical neurons.
Fatigue in Multiple Sclerosis: Neural Correlates and the Role of Non-Invasive Brain Stimulation.
Pediatric multiple sclerosis: update in diagnosis and management.
Pages
« first
‹ previous
…
250
251
252
253
254
255
256
257
258
…
next ›
last »